Related Experiment Video
Updated: Mar 1, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Structure, signaling and the drug discovery of the Ras oncogene protein
Chang Woo Han1, Mi Suk Jeong1, Se Bok Jang1
1Department of Molecular Biology, College of Natural Sciences, Pusan National University, Busan 46241, Korea.
Abstract:
Mutations in Ras GTPase are among the most common genetic alterations in human cancers. Despite extensive research investigating Ras proteins, their functions still remain a challenge over a long period of time. The currently available data suggests that solving the outstanding issues regarding Ras could lead to development of effective drugs that could have a significant impact on cancer treatment. Developing a better understanding of their biochemical properties or modes of action, along with improvements in their pharmacologic profiles, clinical design and scheduling will enable the development of more effective therapies. [BMB Reports 2017; 50(7): 355-360].
Insights
Ras GTPase mutations are common in human cancers. Understanding Ras proteins better could lead to new cancer drugs and more effective therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ras GTPase mutations are frequent genetic alterations in human cancers.
- Despite extensive research, the precise functions of Ras proteins remain incompletely understood.
- Targeting Ras proteins holds significant therapeutic potential for cancer treatment.
Purpose of the Study:
- To highlight the importance of Ras GTPase in cancer.
- To emphasize the need for a deeper understanding of Ras protein functions.
- To underscore the potential for developing novel anti-cancer drugs by addressing current knowledge gaps.
Main Methods:
- Review of existing scientific literature on Ras GTPase.
- Analysis of the implications of Ras mutations in various cancers.
- Discussion of biochemical properties and modes of action of Ras proteins.
Main Results:
- Ras GTPase mutations are a significant driver in numerous human cancers.
- Current knowledge limitations hinder the development of targeted Ras-based therapies.
- Further research into Ras biochemistry and pharmacology is crucial.
Conclusions:
- Resolving outstanding questions about Ras proteins is key to developing effective cancer drugs.
- Improved understanding of Ras biochemical properties and pharmacologic profiles will advance cancer therapy.
- Enhanced clinical design and scheduling of Ras-targeted treatments are necessary for improved patient outcomes.
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

